Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
PLoS One
2012 Jan 01;71:e30580. doi: 10.1371/journal.pone.0030580.
Show Gene links
Show Anatomy links
Trends in the discovery of new marine natural products from invertebrates over the last two decades--where and what are we bioprospecting?
Leal MC
,
Puga J
,
Serôdio J
,
Gomes NC
,
Calado R
.
???displayArticle.abstract???
It is acknowledged that marine invertebrates produce bioactive natural products that may be useful for developing new drugs. By exploring untapped geographical sources and/or novel groups of organisms one can maximize the search for new marine drugs to treat human diseases. The goal of this paper is to analyse the trends associated with the discovery of new marine natural products from invertebrates (NMNPI) over the last two decades. The analysis considers different taxonomical levels and geographical approaches of bioprospected species. Additionally, this research is also directed to provide new insights into less bioprospected taxa and world regions. In order to gather the information available on NMNPI, the yearly-published reviews of Marine Natural Products covering 1990-2009 were surveyed. Information on source organisms, specifically taxonomical information and collection sites, was assembled together with additional geographical information collected from the articles originally describing the new natural product. Almost 10000 NMNPI were discovered since 1990, with a pronounced increase between decades. Porifera and Cnidaria were the two dominant sources of NMNPI worldwide. The exception was polar regions where Echinodermata dominated. The majority of species that yielded the new natural products belong to only one class of each Porifera and Cnidaria phyla (Demospongiae and Anthozoa, respectively). Increased bioprospecting efforts were observed in the Pacific Ocean, particularly in Asian countries that are associated with the Japan Biodiversity Hotspot and the Kuroshio Current. Although results show comparably less NMNPI from polar regions, the number of new natural products per species is similar to that recorded for other regions. The present study provides information to future bioprospecting efforts addressing previously unexplored taxonomic groups and/or regions. We also highlight how marine invertebrates, which in some cases have no commercial value, may become highly valuable in the ongoing search for new drugs from the sea.
???displayArticle.pubmedLink???
22276216
???displayArticle.pmcLink???PMC3262841 ???displayArticle.link???PLoS One
Figure 1. New natural products from marine invertebrate phyla.Cumulative number of new natural products discovered from different marine invertebrate phyla from 1990 to 2009 (Group âOther phylaâ include Annelida, Arthropoda, Brachiopoda, Hemichordata, Platyhelmintes and Bryozoa). Inset: Annual growth of the number of new marine natural products from different marine invertebrate phyla discovered in the 1990s, 2000s and during both decades.
Figure 2. New natural products from Porifera.Cumulative number of new natural products discovered from the most representative families in phylum Porifera from 1990 to 2009. Inset: Annual growth of the number of new marine natural products discovered from the most representative families in phylum Porifera in the 1990s, 2000s and during both decades.
Figure 3. New natural products from Cnidaria.Cumulative number of new natural products discovered from the most representative families in phylum Cnidaria from 1990 to 2009. Inset: Annual growth of the number of new marine natural products discovered from the most representative families in phylum Cnidaria in the 1990s, 2000s and during both decades.
Figure 4. Economic Exclusive Zones.Number of new natural products from marine invertebrates for world Economic Exclusive Zones (EEZ) during the 1990s and the 2000s. Boundaries of Biodiversity Hotspots worldwide are also presented.
Figure 5. Biodiversity Hotspots.Number of new marine natural products from invertebrates (NMNPI) for Biodiversity Hotspots (BH) worldwide during the 1990s and the 2000s (A â Polynesia-Micronesia, B â Caribbean islands, C â Mediterranean basin, D â Indo-Burma, E â Japan).
Figure 6. Large Marine Ecosystems.Number of new marine natural products from invertebrates (NMNPI) for world Large Marine Ecosystems (LME) during the 1990s and the 2000s (A â Caribbean Sea, B â South China Sea, C â East China Sea, D â Kuroshio Current).
Bickford,
Cryptic species as a window on diversity and conservation.
2007, Pubmed
Bickford,
Cryptic species as a window on diversity and conservation.
2007,
Pubmed
Blunt,
Marine natural products.
2011,
Pubmed
Blunt,
Marine natural products.
2005,
Pubmed
Blunt,
Marine natural products.
2006,
Pubmed
Blunt,
Marine natural products.
2007,
Pubmed
,
Echinobase
Blunt,
Marine natural products.
2008,
Pubmed
Blunt,
Marine natural products.
2009,
Pubmed
Blunt,
Marine natural products.
2003,
Pubmed
Blunt,
Marine natural products.
2004,
Pubmed
Blunt,
Marine natural products.
2010,
Pubmed
Chin,
Drug discovery from natural sources.
2006,
Pubmed
Costello,
A census of marine biodiversity knowledge, resources, and future challenges.
2010,
Pubmed
Davidson,
Identification of sibling species of the bryozoan Bugula neritina that produce different anticancer bryostatins and harbor distinct strains of the bacterial symbiont "Candidatus Endobugula sertula".
1999,
Pubmed
Duckworth,
Farming sponges to supply bioactive metabolites and bath sponges: a review.
2009,
Pubmed
Faulkner,
Marine natural products.
2002,
Pubmed
Faulkner,
Marine natural products.
1993,
Pubmed
Faulkner,
Marine natural products.
1994,
Pubmed
Faulkner,
Marine pharmacology.
2000,
Pubmed
Faulkner,
Marine natural products.
1996,
Pubmed
Faulkner,
Marine natural products.
1998,
Pubmed
Faulkner,
Marine natural products.
2000,
Pubmed
Faulkner,
Marine natural products.
2001,
Pubmed
Faulkner,
Highlights of marine natural products chemistry (1972-1999).
2000,
Pubmed
Haefner,
Drugs from the deep: marine natural products as drug candidates.
2003,
Pubmed
Harvey,
Strategies for discovering drugs from previously unexplored natural products.
2000,
Pubmed
Harvey,
Natural products in drug discovery.
2008,
Pubmed
Hentschel,
Molecular evidence for a uniform microbial community in sponges from different oceans.
2002,
Pubmed
Laport,
Marine sponges: potential sources of new antimicrobial drugs.
2009,
Pubmed
Marris,
Marine natural products: drugs from the deep.
2006,
Pubmed
McFadden,
Molecular phylogenetic insights into the evolution of Octocorallia: a review.
2010,
Pubmed
McGovern,
Cryptic species, cryptic endosymbionts, and geographical variation in chemical defences in the bryozoan Bugula neritina.
2003,
Pubmed
Molinski,
Drug development from marine natural products.
2009,
Pubmed
Munro,
The discovery and development of marine compounds with pharmaceutical potential.
1999,
Pubmed
Myers,
Biodiversity hotspots for conservation priorities.
2000,
Pubmed
Paul,
Chemical mediation of interactions among marine organisms.
2004,
Pubmed
Paul,
Marine chemical ecology in benthic environments.
2011,
Pubmed
Paul,
Marine chemical ecology.
2008,
Pubmed
Ramesh,
New oxygenated africanenes from the soft coral sinularia dissecta.
1999,
Pubmed
Roberts,
Marine biodiversity hotspots and conservation priorities for tropical reefs.
2002,
Pubmed
Skropeta,
Deep-sea natural products.
2008,
Pubmed
Su,
Oxygenated cembranoids from the cultured and wild-type soft corals Sinularia flexibilis.
2009,
Pubmed
Tan,
Biodiversity as a source of anticancer drugs.
2006,
Pubmed
Wen,
Sinulaflexiolides A-K, cembrane-type diterpenoids from the chinese soft coral Sinularia flexibilis.
2008,
Pubmed
Wijffels,
Potential of sponges and microalgae for marine biotechnology.
2008,
Pubmed
Yu,
5,8-Epidioxysterols and related derivatives from a Chinese soft coral Sinularia flexibilis.
2006,
Pubmed